GLP-1 Pharmacy Index

A proposed GLP-1 pharmacy index would track dose availability and cash prices by ZIP code for consumers and business buyers.

Possible Drug-Drug Interactions Flagged For Older Americans

Health trend signals increased concern over potential drug interactions among seniors, prompting calls for greater medication oversight and research.

Nurse Spreads Vaccine Misinfo; MD Vs PBM; Growing Pains Or Red Flags?

A nurse’s public sharing of vaccine misinformation sparks debate over healthcare provider roles and trust issues, raising concerns about growing pains or red flags.

Automatischer Pillenspender: Wenn es das tägliche Leben deutlich sicherer macht

Discover the top automatic pill dispensers of 2026. Find the best overall, value, and specialized options to suit your medication management needs.

Wöchentliche Pillendosen im Vergleich: Welche Anordnung Hilft Wirklich

Discover the top weekly pill organizers for 2026. Find the best overall, budget-friendly, and specialized options to suit your medication needs.

Medikamentenspender für Demenz: Wenn automatische Systeme Angehörige entlasten

Find the best medication dispenser for dementia in 2026. Our top picks include the overall best, budget-friendly options, and premium picks for safety and ease.

Medikamenten-Erinnerung zu Hause: Wenn einfache Geräte nützlicher sind als Apps

Discover the top medication reminder devices of 2026. Find the best options for seniors, caregivers, and those with specific needs in this comprehensive guide.

Prostitution And Drug Bust In Ankara: 15 Detained

Authorities in Ankara have detained 15 suspects in a crackdown involving prostitution, drug trafficking, and illegal prescription medications found at multiple addresses.

Vitruvias Therapeutics Thyroid Tablet Recall

Vitruvias Therapeutics has initiated a recall of certain thyroid tablets due to potential safety issues. No injuries or adverse events reported yet.

At Shambhala Music Festival, A Plan To Make Drugs Like Ketamine And MDMA Safer

Shambhala Music Festival introduces a program aimed at reducing risks associated with drugs like MDMA and ketamine, focusing on harm reduction strategies.